Certainly, the up-regulation of GRK2 (and also probably GRK5) caused by SNS activation acts as a “brake” for cardiac βAR signaling and this is a partial reason why β-blockers have some beneficial effects in HF as they can block the noxious effects of catecholamines on the cardiac myocyte. This evidence concerns the gene GRK2 and hydrops fetalis.